Effect of Huaji Jianpi Prescription Combined with Hypocaloric Enteral Nutrition Support on Nutritional Status and Cellular Immunity of Patients with Primary Hepatic Cancer After Transcatheter Hepatic Arterial Chemoembolization
Objective:To observe the effect of Huaji Jianpi prescription combined with hypocaloric enteral nutrition support on nutritional status and cellular immunity of patients with primary hepatic cancer after receiving transcatheter hepatic arterial chemoembolization(TACE).Methods:Divided 80 cases of patients with primary hepatic cancer(liver-stagnation and spleen-deficiency type as well as accumulation of blood stasis type)after the treatment of TACE into two groups,40 cases in each group.Both groups receivedhypocaloric enteral nutrition support after the operation,while the observation group was additionally treated with Huaji Jianpi prescription for four weeks as a course.Compared the improvements of the immune function of T lymphocytes CD4+,CD3+and CD4+/CD8+before and after treatment,as well as the improvements of nutritional indexes such as hemoglobin(Hb),albumin(Alb)and serum total protein(TP).Compared the clinical effect and complications between the two groups.Results:After treatment,immune indexes of T lymphocytes CD4+,CD3+and CD4+/CD8+as well as nutritional indexes such as Hb,TP and Alb in the observation group were all increased and were all being higher than those in the control group,differences being significant(P<0.05).The total effective rate was 70.0%in the control group and 90.0%in the observation group,the difference being significant in the intergroup comparison(P<0.05).The total incidence rate of complication was 25.0%in the control group and 7.5%in the observation group,the difference being significant(P<0.05).Conclusion:The therapy of Huaji Jianpi prescription combined with hypocaloric enteral nutrition support for primary hepatic cancer after the treatment of TACE has remarkable clinical effect.It can evidently improve the nutritional status and immunity as well as decline the incidence rate of complication.